Shikonin Causes Non-apoptotic Cell Death in B16F10 Melanoma


Дәйексөз келтіру

Толық мәтін

Аннотация

Background: Melanoma treatment is highly resistant to current chemotherapeutic agents. Due to its resistance towards apoptotic cell death, non-apoptotic cell death pathways are sought after.

Objective: We investigated a Chinese herbal medicine, shikonin, and its effect on B16F10 melanoma cells in vitro.

Methods: Cell growth of B16F10 melanoma cells treated with shikonin was analyzed using an MTT assay. Shikonin was combined with necrostatin, an inhibitor of necroptosis; caspase inhibitor; 3-methyladenine, an inhibitor of autophagy; or N-acetyl cysteine, an inhibitor of reactive oxygen species. Flow cytometry was used to assess types of cell death resulting from treatment with shikonin. Cell proliferation was also analyzed utilizing a BrdU labeling assay. Monodansylcadaverine staining was performed on live cells to gauge levels of autophagy. Western blot analysis was conducted to identify specific protein markers of necroptosis including CHOP, RIP1, and pRIP1. MitoTracker staining was utilized to identify differences in mitochondrial density in cells treated with shikonin.

Results: Analysis of MTT assays revealed a large decrease in cellular growth with increasing shikonin concentrations. The MTT assays with necrostatin, 3-methyladenine, and N-acetyl cysteine involvement, suggested that necroptosis, autophagy, and reactive oxygen species are a part of shikonin's mechanism of action. Cellular proliferation with shikonin treatment was also decreased. Western blotting confirmed that shikonin-treated melanoma cells increase levels of stress-related proteins, e.g., CHOP, RIP, pRIP.

Conclusion: Our findings suggest that mainly necroptosis is induced by the shikonin treatment of B16F10 melanoma cells. Induction of ROS production and autophagy are also involved.

Авторлар туралы

Haleema Ahmad

Department of Biochemistry, A.T. Still University

Email: info@benthamscience.net

Megan Crotts

Department of Biochemistry, A.T. Still University

Email: info@benthamscience.net

Jena Jacobs

Department of Biochemistry, A.T. Still University

Email: info@benthamscience.net

Robert Baer

Department of Physiology, Kirksville College of Osteopathic Medicine, A.T. Still University

Email: info@benthamscience.net

James Cox

Department of Biochemistry, A.T. Still University

Хат алмасуға жауапты Автор.
Email: info@benthamscience.net

Әдебиет тізімі

  1. Arnold, M.; Singh, D.; Laversanne, M.; Vignat, J.; Vaccarella, S.; Meheus, F.; Cust, A.E.; de Vries, E.; Whiteman, D.C.; Bray, F. Global burden of cutaneous melanoma in 2020 and projections to 2040. JAMA Dermatol., 2022, 158(5), 495-503. doi: 10.1001/jamadermatol.2022.0160 PMID: 35353115
  2. Song, X.; Zhao, Z.; Barber, B.; Farr, A.M.; Ivanov, B.; Novich, M. Overall survival in patients with metastatic melanoma. Curr. Med. Res. Opin., 2015, 31(5), 987-991. doi: 10.1185/03007995.2015.1021904 PMID: 25708472
  3. Yang, A.S.; Chapman, P.B. The history and future of chemotherapy for melanoma. Hematol. Oncol. Clin. North Am., 2009, 23(3), 583-597. doi: 10.1016/j.hoc.2009.03.006 PMID: 19464604
  4. Alarifi, S.; Ali, D.; Alkahtani, S.; Almeer, R.S. ROS-mediated apoptosis and genotoxicity induced by palladium nanoparticles in human skin malignant melanoma cells. Oxid. Med. Cell. Longev., 2017, 2017, 1-10. doi: 10.1155/2017/8439098 PMID: 28791053
  5. Zeng, L.; Gowda, B.H.J.; Ahmed, M.G.; Abourehab, M.A.S.; Chen, Z.S.; Zhang, C.; Li, J.; Kesharwani, P. Advancements in nanoparticle-based treatment approaches for skin cancer therapy. Mol. Cancer, 2023, 22(1), 10. doi: 10.1186/s12943-022-01708-4 PMID: 36635761
  6. Palliyage, G.H.; Hussein, N.; Mimlitz, M.; Weeder, C.; Alnasser, M.H.A.; Singh, S.; Ekpenyong, A.; Tiwari, A.K.; Chauhan, H. Novel curcumin-resveratrol solid nanoparticles synergistically inhibit proliferation of melanoma cells. Pharm. Res., 2021, 38(5), 851-871. doi: 10.1007/s11095-021-03043-7 PMID: 33982225
  7. Sudha, T.; Salaheldin, T.A.; Darwish, N.H.E.; Mousa, S.A. Antitumor/anti-angiogenesis efficacy of epigallocatechin gallate nanoformulated with antioxidant in melanoma. Nanomedicine, 2022, 17(15), 1039-1053. doi: 10.2217/nnm-2021-0362 PMID: 36102916
  8. Arya, J.S.; Joseph, M.M.; Sherin, D.R.; Nair, J.B.; Manojkumar, T.K.; Maiti, K.K. Exploring mitochondria-mediated intrinsic apoptosis by new phytochemical entities: an explicit observation of cytochrome c dynamics on lung and melanoma cancer cells. J. Med. Chem., 2019, 62(17), 8311-8329. doi: 10.1021/acs.jmedchem.9b01098 PMID: 31393121
  9. Hammerová, J.; Uldrijan, S.; Táborská, E.; Vaculová, A.H.; Slaninová, I. Necroptosis modulated by autophagy is a predominant form of melanoma cell death induced by sanguilutine. Biol. Chem., 2012, 393(7), 647-658. doi: 10.1515/hsz-2011-0279 PMID: 22944669
  10. Mbaveng, A.T.; Chi, G.F.; Bonsou, I.N.; Abdelfatah, S.; Tamfu, A.N.; Yeboah, E.M.O.; Kuete, V.; Efferth, T. N-acetylglycoside of oleanolic acid (aridanin) displays promising cytotoxicity towards human and animal cancer cells, inducing apoptotic, ferroptotic and necroptotic cell death. Phytomedicine, 2020, 76, 153261. doi: 10.1016/j.phymed.2020.153261 PMID: 32559584
  11. Makin, G.; Hickman, J.A. Apoptosis and cancer chemotherapy. Cell Tissue Res., 2000, 301(1), 143-152. doi: 10.1007/s004419900160 PMID: 10928287
  12. Soengas, M.S.; Lowe, S.W. Apoptosis and melanoma chemoresistance. Oncogene, 2003, 22(20), 3138-3151. doi: 10.1038/sj.onc.1206454 PMID: 12789290
  13. Shahsavari, Z.; Karami-Tehrani, F.; Salami, S. Shikonin induced necroptosis via reactive oxygen species in the t-47d breast cancer cell line. Asian Pac. J. Cancer Prev., 2015, 16(16), 7261-7266. doi: 10.7314/APJCP.2015.16.16.7261 PMID: 26514521
  14. Shahsavari, Z.; Karami-Tehrani, F.; Salami, S.; Ghasemzadeh, M. RIP1K and RIP3K provoked by shikonin induce cell cycle arrest in the triple negative breast cancer cell line, MDA-MB-468: necroptosis as a desperate programmed suicide pathway. Tumour Biol., 2016, 37(4), 4479-4491. doi: 10.1007/s13277-015-4258-5 PMID: 26496737
  15. Zhang, Z.; Zhang, Z.; Li, Q.; Jiao, H.; Chong, D.; Sun, X.; Zhang, P.; Huo, Q.; Liu, H. Shikonin induces necroptosis by reactive oxygen species activation in nasopharyngeal carcinoma cell line CNE-2Z. J. Bioenerg. Biomembr., 2017, 49(3), 265-272. doi: 10.1007/s10863-017-9714-z PMID: 28547157
  16. Chen, X.; Yang, L.; Zhang, N.; Turpin, J.A.; Buckheit, R.W.; Osterling, C.; Oppenheim, J.J.; Howard, O.M.Z. Shikonin, a component of chinese herbal medicine, inhibits chemokine receptor function and suppresses human immunodeficiency virus type 1. Antimicrob. Agents Chemother., 2003, 47(9), 2810-2816. doi: 10.1128/AAC.47.9.2810-2816.2003 PMID: 12936978
  17. Andújar, I.; Martí-Rodrigo, A.; Giner, R.; Ríos, J.; Recio, M. Shikonin prevents early phase inflammation associated with azoxymethane/dextran sulfate sodium-induced colon cancer and induces apoptosis in human colon cancer cells. Planta Med., 2018, 84(09/10), 674-683. doi: 10.1055/a-0599-1145 PMID: 29642242
  18. Hotchkiss, R.S.; Strasser, A.; McDunn, J.E.; Swanson, P.E. Cell Death. N. Engl. J. Med., 2009, 361(16), 1570-1583. doi: 10.1056/NEJMra0901217 PMID: 19828534
  19. Kroemer, G.; Galluzzi, L.; Vandenabeele, P.; Abrams, J.; Alnemri, E.S.; Baehrecke, E.H.; Blagosklonny, M.V.; El-Deiry, W.S.; Golstein, P.; Green, D.R.; Hengartner, M.; Knight, R.A.; Kumar, S.; Lipton, S.A.; Malorni, W.; Nuñez, G.; Peter, M.E.; Tschopp, J.; Yuan, J.; Piacentini, M.; Zhivotovsky, B.; Melino, G. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ., 2009, 16(1), 3-11. doi: 10.1038/cdd.2008.150 PMID: 18846107
  20. Chude, C.; Amaravadi, R. Targeting autophagy in cancer: update on clinical trials and novel inhibitors. Int. J. Mol. Sci., 2017, 18(6), 1279. doi: 10.3390/ijms18061279 PMID: 28621712
  21. Han, W.; Xie, J.; Fang, Y.; Wang, Z.; Pan, H. Nec-1 enhances shikonin-induced apoptosis in leukemia cells by inhibition of RIP-1 and ERK1/2. Int. J. Mol. Sci., 2012, 13(6), 7212-7225. doi: 10.3390/ijms13067212 PMID: 22837689
  22. Hu, H.; Tian, M.; Ding, C.; Yu, S. The C/EBP Homologous Protein (CHOP) transcription factor functions in endoplasmic reticulum stress-induced apoptosis and microbial infection. Front. Immunol., 2019, 9, 3083. doi: 10.3389/fimmu.2018.03083 PMID: 30662442
  23. Festjens, N.; Vanden, B. T.; Cornelis, S.; Vandenabeele, P. RIP1, a kinase on the crossroads of a cell's decision to live or die. Cell Death Differ., 2007, 14(3), 400-410. doi: 10.1038/sj.cdd.4402085 PMID: 17301840
  24. R: a language and environment for statistical computing. 2022. Available from: https://www.R-project.org/
  25. Wickham, H.; Averick, M.; Bryan, J.; Chang, W.; McGowan, L.; François, R.; Grolemund, G.; Hayes, A.; Henry, L.; Hester, J.; Kuhn, M.; Pedersen, T.; Miller, E.; Bache, S.; Müller, K.; Ooms, J.; Robinson, D.; Seidel, D.; Spinu, V.; Takahashi, K.; Vaughan, D.; Wilke, C.; Woo, K.; Yutani, H. Welcome to the Tidyverse. J. Open Source Softw., 2019, 4(43), 1686. doi: 10.21105/joss.01686
  26. Hammill, D. CytoExploR: Interactive Analysis of Cytometry Data. 2021. Available from: https://dillonhammill.github.io/CytoExploreR/
  27. Van, P.; Jiang, W.; Gottardo, R.; Finak, G. ggCyto: next generation open-source visualization software for cytometry. Bioinformatics, 2018, 34(22), 3951-3953. doi: 10.1093/bioinformatics/bty441 PMID: 29868771
  28. Huang, C.; Luo, Y.; Zhao, J.; Yang, F.; Zhao, H.; Fan, W. Shikonin kills glioma cells through necroptosis mediated by RIP-1. PLoS ONE, 2013, 8(6), e66326.
  29. Han, W.; Li, L.; Qiu, S.; Lu, Q.; Pan, Q.; Gu, Y.; Luo, J.; Hu, X. Shikonin circumvents cancer drug resistance by induction of a necroptotic death. Mol. Cancer Ther., 2007, 6(5), 1641-1649. doi: 10.1158/1535-7163.MCT-06-0511 PMID: 17513612
  30. Wang, H.; Liu, Z.; Li, X.; Zhao, R.; Pu, Y.; Wu, H. Shikonin causes apoptosis by disrupting intracellular calcium homeostasis and mitochondrial function in human hepatoma cells. Exp. Ther. Med., 2017, 15(2), 1484-1492. doi: 10.3892/etm.2017.5591
  31. Glinsky, G.V.; Glinsky, V.V. Apoptosis and metastasis: a superior resistance of metastatic cancer cells to programmed cell death. Cancer Lett., 1996, 101(1), 43-51. doi: 10.1016/0304-3835(96)04112-2 PMID: 8625281
  32. Geserick, P.; Wang, J.; Schilling, R.; Horn, S.; Harris, P.A.; Bertin, J.; Gough, P.J.; Feoktistova, M.; Leverkus, M. Absence of RIPK3 predicts necroptosis resistance in malignant melanoma. Cell Death Dis., 2015, 6(9), e1884-e1884. doi: 10.1038/cddis.2015.240 PMID: 26355347
  33. Nishitoh, H. CHOP is a multifunctional transcription factor in the ER stress response. J. Biochem., 2012, 151(3), 217-219. doi: 10.1093/jb/mvr143 PMID: 22210905
  34. Oberst, A. Death in the fast lane: what's next for necroptosis? FEBS J., 2016, 283(14), 2616-2625. doi: 10.1111/febs.13520 PMID: 26395133
  35. Shahsavari, Z.; Karami-Tehrani, F.; Salami, S. Targeting cell necroptosis and apoptosis induced by shikonin via receptor interacting protein kinases in estrogen receptor positive breast cancer cell line, MCF-7. Anticancer. Agents Med. Chem., 2018, 18(2), 245-254. doi: 10.2174/1871520617666170919164055 PMID: 28933271
  36. Xu, Q.; Mariman, E.C.M.; Blaak, E.E.; Jocken, J.W.E. Pharmacological agents targeting autophagy and their effects on lipolysis in human adipocytes. Mol. Cell. Endocrinol., 2022, 544, 111555. doi: 10.1016/j.mce.2022.111555 PMID: 35031432
  37. Kosic, M.; Paunovic, V.; Ristic, B.; Mircic, A.; Bosnjak, M.; Stevanovic, D.; Kravic-Stevovic, T.; Trajkovic, V.; Harhaji-Trajkovic, L. 3-Methyladenine prevents energy stress-induced necrotic death of melanoma cells through autophagy-independent mechanisms. J. Pharmacol. Sci., 2021, 147(1), 156-167. doi: 10.1016/j.jphs.2021.06.003 PMID: 34294367
  38. Liu, Y.; Kang, X.; Niu, G.; He, S.; Zhang, T.; Bai, Y.; Li, Y.; Hao, H.; Chen, C.; Shou, Z.; Li, B. Shikonin induces apoptosis and prosurvival autophagy in human melanoma A375 cells via ROS-mediated ER stress and p38 pathways. Artif. Cells Nanomed. Biotechnol., 2019, 47(1), 626-635. doi: 10.1080/21691401.2019.1575229 PMID: 30873870
  39. Wang, A.; Liu, J.; Yang, Y.; Chen, Z.; Gao, C.; Wang, Z.; Fu, C.; Zou, L.; Wang, S. Shikonin promotes ubiquitination and degradation of cIAP1/2-mediated apoptosis and necrosis in triple negative breast cancer cells. Chin. Med., 2021, 16(1), 16. doi: 10.1186/s13020-021-00426-1 PMID: 33526051
  40. García-Hevia, L.; Valiente, R.; Martín-Rodríguez, R.; Renero-Lecuna, C.; González, J.; Rodríguez-Fernández, L.; Aguado, F.; Villegas, J.C.; Fanarraga, M.L. Nano-ZnO leads to tubulin macrotube assembly and actin bundling, triggering cytoskeletal catastrophe and cell necrosis. Nanoscale, 2016, 8(21), 10963-10973. doi: 10.1039/C6NR00391E PMID: 27228212
  41. Guo, C.; He, J.; Song, X.; Tan, L.; Wang, M.; Jiang, P.; Li, Y.; Cao, Z.; Peng, C. Pharmacological properties and derivatives of shikonin—A review in recent years. Pharmacol. Res., 2019, 149, 104463. doi: 10.1016/j.phrs.2019.104463 PMID: 31553936

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bentham Science Publishers, 2023